Customized Antibodies, CAR-T & Protein Services
Fueling A New Era In Medicine
Since 2001, ProMab has built in-house expertise in the latest technologies to help our partners push the frontiers of medicine.
Today, we are the only provider that can offer CAR-T/NK development, mRNA-LNP development, and antibody engineering-highly promising technologies on their own and even more powerful when combined.
Turn tumors into cancer vaccines, manufacture antibodies in the body, build allogeneic cell therapies... imagine the possibilities and we'll help you bring them to life.
monoclonal antibodies generated
CAR-T project finished
Phase 2 clinical trials started
mRNA-Lipid Nanoparticle Development
Leverage our validated platform to advance your studies into the use of LNP-based delivery of mRNAs, including the development of vaccines, protein replacement therapies, engineered immune cells, or antibody-encoding mRNA therapies.